Is Arcutis Biotherapeutics, Inc. (ARQT) a Buy, Sell, or Hold?
Arcutis Biotherapeutics, Inc.
NASDAQ:ARQT
$27.78 USD
$0.97 (3.62%)
- Volume
- 1.46M
- Average Volume
- 1.78M
- Market Capitalization
- $3.47B
- P/E Ratio
- -1446.88
- Dividend Yield
- 0.00%
- Price Target
- $34.00
- Year High
- $31.77
- Year Low
- $13.70
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.68
ARQT vs. The Competition
| Properties | ARQT | CELC | CGON | CNTA |
|---|---|---|---|---|
| Market Cap | $3.47B | $4.46B | $6.44B | $6.27B |
| Shares Outstanding | $125.08M | $48.77M | $88.2M | $154.73M |
| P/E Ratio | -1446.88 | -23.52 | -31.2 | -22.75 |
| EPS | -0.02 | -3.54 | -2.21 | -1.63 |
| Day Low | 26.5 | 85 | 69.97 | 40.5 |
| Day high | 27.98 | 98 | 74.79 | 40.5 |
| Year Low | 13.695 | 13.47 | 23.65 | 12.78 |
| Year High | 31.77 | 151.02 | 77 | 40.56 |
| Average Price 50 | 23.8508 | 111.714 | 65.3644 | 39.7066 |
| Average Price 200 | 24.83365 | 101.45875 | 54.94828 | 29.33188 |
| Volume | 1.46M | 8.75M | 1.11M | - |
| Average Volume | - | - | - | - |